Molecular and Cellular Oncology

Top Research Topics at Molecular and Cellular Oncology?

The main research concerns discussed in the journal are Cancer research, Cell biology, Cancer, Cancer cell and Carcinogenesis. The studies on Cancer research discussed can also contribute to research in the domains of Cancer stem cell, Immunology, Metastasis, Breast cancer and Kinase. Topics in Cell biology explored in the journal were investigated in conjunction with research in Autophagy, Apoptosis, Programmed cell death and DNA damage.

Research in DNA damage tackled falls within the umbrella of DNA. The journal is concerned with the study of Cancer and Genetics in general.

• Cancer research (41.82%)
• Cell biology (40.25%)
• Cancer (19.60%)

What are the most cited papers published in the journal?

• The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents (173 citations)
• Chloroquine and hydroxychloroquine for cancer therapy (124 citations)
• Autophagy, cell death, and cancer. (120 citations)

Research areas of the most cited articles at Molecular and Cellular Oncology:

The published papers are mainly concerned with subjects like Cancer research, Cell biology, Cancer, Programmed cell death and Carcinogenesis. The works on Cancer research tackled in the journal papers bring together disciplines like Bioinformatics, Mutation, Progenitor cell, Enzyme and Molecular biology. The published articles explore issues in Cell biology which can be linked to other research areas like Cancer cell, Autophagy, Apoptosis and Cell.

What topics the last edition of the journal is best known for?

• Gene
• Cancer
• Enzyme

The previous edition focused in particular on these issues:

The journal investigates areas of study like Cell biology, Cancer research, Cancer, Autophagy and DNA damage. The tackled Cell biology research is interrelated with Transcription (biology) which concerns subjects like Genome. Protein kinase B, Metastasis, Activator (genetics), Tumor progression and PI3K/AKT/mTOR pathway are some topics wherein Cancer research research discussed in Molecular and Cellular Oncology have an impact.

The journal explores research in PI3K/AKT/mTOR pathway alongside concepts in Serine and other areas of study in Kinase. Some problems in Cancer that were presented in Molecular and Cellular Oncology overlapped with concepts under Biomarker (medicine), Oncology and Pan cancer. The field of DNA is the anchor for the DNA damage studies presented in it.

The most cited articles from the last journal are:

• Inducing DNA damage through R-loops to kill cancer cells. (2 citations)
• The complex role of SIRT7 in p53 stabilization: nucleophosmin joins the debate. (1 citations)
• p62/SQSTM1 droplets initiate autophagosome biogenesis and oxidative stress control. (1 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Molecular and Cellular Oncology (based on the number of publications) are:

• Guido Kroemer (13 papers) published 1 paper at the last edition, 1 less than at the previous edition,
• Rugang Zhang (5 papers) absent at the last edition,
• Florine Obrist (5 papers) absent at the last edition,
• Lorenzo Galluzzi (5 papers) published 1 paper at the last edition,
• Boyi Gan (4 papers) published 1 paper at the last edition the same number as at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Molecular and Cellular Oncology (based on the number of publications) are:

• University of Texas MD Anderson Cancer Center (26 papers) published 1 paper at the last edition, 2 less than at the previous edition,
• French Institute of Health and Medical Research (26 papers) absent at the last edition,
• Harvard University (20 papers) published 3 papers at the last edition, 1 more than at the previous edition,
• University of Texas Southwestern Medical Center (15 papers) published 1 paper at the last edition, 2 less than at the previous edition,
• National Institutes of Health (14 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.79% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 16.90% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.04% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 25.35% of all publications and 50.70% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.